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Abstract 
 Many members of the C-type lectin 
family of glycan-binding receptors have 
been ascribed roles in the recognition of 
microorganisms and serve as key 
receptors in the innate immune response 
to pathogens. Other mammalian 
receptors have become targets through 
which pathogens enter target cells. These 
receptor roles have often been 
documented with binding studies 
involving individual pairs of receptors 
and micro-organisms. To provide a 
systematic overview of interactions 
between microbes and the large 
complement of C-type lectins, here we 
developed a lectin array and suitable 
protocols for labeling of microbes that 
could be used to probe this array. The 
array contains C-type lectins from cow, 
chosen as a model organism of 
agricultural interest for which the 
relevant pathogen–receptor interactions 
have not been previously investigated in 
detail. Screening with yeast cells and 
various strains of both Gram-positive and 
-negative bacteria revealed distinct 
binding patterns, which in some cases 
could be explained by binding to lipopoly-
saccharides or capsular polysaccharides, 
but in other cases suggested the presence 
of novel glycan targets on many of the 
microorganisms. These results are 
consistent with interactions previously 
ascribed to the receptors, but also 
highlight binding to additional sugar 
targets that have not previously been 
recognized. Our findings indicate that 
mammalian lectin arrays represent 
unique discovery tools for identifying 
both novel ligands and new receptor 
functions.   
_______________________________________ 
 
 Soluble and membrane-bound mammalian 
glycan-binding proteins in the C-type lectin 
family are responsible for recognition of micro-
organisms and for cell-cell interactions (1,2). 
Sugar-binding activity of these receptors resides 
in modular carbohydrate-recognition domains 
(CRDs) and is based on ligation of adjacent 
hydroxyl groups, usually at the 3- and 4-position 
in a monosaccharide target, to a conserved Ca2+ 
in the primary binding site. The CRDs in the 
roughly 25 members of the family fall broadly 
into two groups: those that interact with sugars 
related to mannose and GlcNAc, through their 
equatorial 3- and 4-OH groups, and those that 
interact with galactose and GalNAc, in which 
the 4-OH group is axial. Many CRDs in the 
mannose-recognition group also bind to fucose. 
Binding to ligands depends on the presence of 
free OH groups. Thus, target monosaccharides 
are often found in the non-reducing ends of 
oligosaccharides. Selective binding to specific 
oligosaccharide ligands results from additional 
interactions with further sugars residues in 
secondary binding sites. 
 The C-type lectins play multiple roles in the 
innate immune system. The soluble C-type 
lectins are collectins, which contain collagen-
like domains in addition to the C-type CRDs (3). 
Collectins are mostly found in blood and in the 
surfactant layer on the surface of the alveolar 
fluid in the lungs. These proteins aid in 
neutralization of pathogens by activating 
complement, by opsonizing proteins for uptake 
by complement-binding receptors on 
macrophages, and by causing agglutination. 
Membrane-bound C-type lectins are found on 
various cells of the innate system, including 
macrophages and dendritic cells (1). Many of 
these receptors mediate endocytosis of ligands, 
which can be a route for neutralizing pathogens 
as well as subsequently stimulating the adaptive 
immune response. C-type lectins involved in 
endocytosis are also found on hepatocytes and 
vascular endothelial cells (2). 
 Extensive genomic and biochemical analysis 
has provided a nearly complete account of 
receptors containing C-type CRDs in the human 
immune system, but C-type lectins from other 
mammals, apart from mouse, have not been as 
well studied. Because there are many differences 
between the mouse and human immune systems 
there is need to study other species. Cows are 
not only important agriculturally, but can also be 
a useful model for infectious diseases in humans 
(4,5). For example, mouse models of 
tuberculosis do not mimic the pathology of the 
disease in humans while tuberculosis in cattle 
and humans is more similar. In addition, due to 
the large size and large blood volume of cattle, 
immune cells can quite easily be obtained from 
various tissues, making cattle attractive models 
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for studying cellular effects of lectin-microbe 
interactions. Investigation of the cow immune 
response is also important for understanding 
potential zoonotic diseases. 
 Screening of large glycan arrays has been 
instrumental in determining specificity of lectins 
from various mammalian species for mammalian 
oligosaccharides (6-8). However, the lower 
availability of pure, well-characterized glycans 
from micro-organisms is a limitation for using 
glycan arrays to study lectin-pathogen 
interactions. Arrays of glycans purified from 
natural sources or chemically synthesized 
provide one way to probe these interactions (9-
11). Unfortunately, the vast majority of glycans 
found on bacteria, fungi, viruses and parasites 
are not available in this format. 
 Lectin arrays have previously been 
constructed using plant and bacterial lectins for 
the purpose of deducing the structures of glycans 
present in samples such as glycoproteins and 
performing other types of glycomic analysis 
(12,13). As an alternative approach, a 
mammalian lectin array provides the opportunity 
to screen many different lectins simultaneously 
with labeled, intact micro-organisms to develop 
a profile of which receptors interact with each 
organism. Use of a lectin array constructed with 
bovine C-type lectins provides a rapid way to 
perform comparative analysis of specificity of 
C-type lectins and inform future studies to 
determine the roles of different lectins in the 
immune system and potentially to develop 
carbohydrate-based vaccines. 
 A model mammalian lectin array has been 
developed using carbohydrate-recognition 
domains (CRDs) from bovine C-type lectins 
modified with single-site biotin tags. The array 
has been used to reveal novel and unexpected 
interactions between bacteria and the receptors 
of the innate immune system. 
 
Results 
Identification of bovine glycan-binding 
receptors that contain C-type CRDs 
 Bovine genomic sequences in the National 
Center for Biotechnology Information databases 
were screened for annotated instances of the C-
type CRD motif. In order to distinguish sugar-
binding proteins from C-type lectin-like 
domains, the presence of amino acids at 
positions for ligating to the conserved Ca2+ was 
used to sort the annotated sequences (14). Based 
on these criteria, 32 potential sugar-binding 
proteins were identified. Most of these proteins 
could be identified as orthologs of human and 
murine proteins and the names assigned in the 
National Center for Biotechnology Information 
database reflects accurately the fact that the 
proteins share the same overall domain 
organization as the corresponding human 
orthologs and the sequences of the CRDs are 
largely conserved (1). Most receptors found in 
the immune system of humans, including 
mincle, the receptor for trehalose dimycolate on 
mycobacteria, and dectin-1, which binds to β-
glucans on fungi, are well-conserved in cows 
(15,16). However, there is a single form of DC-
SIGN in cows, compared to two in humans, and 
several members of the collectin subfamily, 
including conglutinin, CL-43 and CL-46, appear 
to be ruminant-specific sugar-binding receptors 
(17,18). 
 For the purposes of producing a prototype 
mammalian lectin array for analyzing 
interactions with microbes, CRDs from the 23 
proteins highlighted in Fig. 1 were selected, 
based on their expression on cells of the innate 
immune system and exposure to the blood 
compartment. The cow ortholog of dectin-1 was 
also included as it is the only protein in which a 
domain with the C-type lectin fold has been 
shown to have sugar-binding activity in spite of 
lacking a canonical Ca2+-binding site (19). A 
mutant version of this protein, which is linked to 
Johne's disease, was also included for 
comparison (20). The resulting catalog of C-type 
CRD sequences is given in Fig. S1.  
 
Strategy for development of lectin array 
 Construction of the lectin array was based on 
use of biotinylation tags to display the CRDs in 
defined orientations on streptavidin-coated 
wells. Biotinylation was achieved by appending 
a 13-amino acid biotinylation sequence at one 
end of the CRD (21). A lysine residue in this 
sequence is a target for biotin ligase, which can 
be co-expressed with receptor fragments in 
Escherichia coli for biotinylation in vivo (22). 
Alternatively, the purified enzyme can be used 
to treat fragments in vitro. The arrangements of 
different C-type lectins are summarized in Fig. 
2A, along with different ways in which N- and 
C-terminal biotinylation sequences have been 
used for immobilization. Because both ends of 
the polypeptide project from the face of the CRD 
opposite to the sugar-binding site, 
immobilization through tags attached to the ends 
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of the CRDs orients the sugar-binding site 
projecting away from the surface of the wells. In 
a few cases, additional fragments larger than 
single CRDs have been included. The mannose 
receptor contains eight C-type lectin-like 
domains (23). CRD 4 has been shown to be the 
main site of sugar binding, but a pair of domains 
containing CRDs 4 and 5 has enhanced sugar-
binding activity, so this two-domain fragment is 
also included in the array. As a further test case, 
attachment of an N-terminal biotin tag to the full 
extracellular portion of the Kupffer cell receptor 
mimics the orientation of the trimeric receptor at 
the cell surface (24). 
 Most of the tagged CRD fragments were 
prepared by expression in E. coli, followed by 
solubilization of inclusion bodies in guanidine 
and renaturation by dialysis and purification by 
affinity chromatography on immobilized sugars 
following protocols developed for many of these 
proteins from other species. This approach 
ensures that the proteins are correctly folded and 
have sugar-binding activity. Dectin-1 was 
purified by ion exchange chromatography. Ca2+-
independent sugar-binding activity was 
confirmed by immobilization in streptavidin-
coated cells and probing with fluorescein-
conjugated zymosan from Saccharomyces 
cerevisiae as described below. Collectin ColL1 
was also purified by conventional 
chromatography. SDS-polyacrylamide gel 
electrophoresis in the presence and absence of 
reducing agents indicated that disulfide bonds 
were formed as expected. However, no suitable 
sugar-containing target ligands have been 
identified, so it was impossible to prove 
unambiguously that it was correctly folded. 
 For each CRD preparation, a series of 
different concentrations were tested in the 
streptavidin-coated wells. Probing with 
fluorescein-conjugated zymosan was used to 
determine what concentration of CRD was 
required to ensure saturation of the streptavidin 
in the wells. Examples of the results for DC-
SIGN, dectin-2 and langerin are shown in Fig. 3. 
Based on these results, aliquots of each receptor 
preparation suitable for coating four wells were 
lyophilized. For the proteins that did not bind 
zymosan, collectin ColL1, SP-A, and mincle, 
saturation coating of the wells was confirmed by 
elution of the coated protein from the wells with 
SDS and analysis by SDS-polyacrylamide gel 
electrophoresis. Arrays were then generated by 
dissolving the panel of aliquots and coating the 
wells in parallel. 
 
Validation of array using yeast zymosan 
 Initial tests of the array were performed using 
zymosan particles derived from Saccharomyces 
cerevisiae because this preparation contains 
multiple types of sugar structures and binds to 
most of the C-type CRDs (Fig. 4A). Screening 
of the prototype array with zymosan confirms 
this broad spectrum of binding (Fig. 4B). The 
lectins have been grouped based on their primary 
monosaccharide-binding properties. Interaction 
with the mannose-binding CRDs is not 
surprising, given the abundance of mannan 
structures on the surface of yeast. Interaction of 
zymosan with galactose-binding receptors has 
been previously reported and presumably 
reflects the presence of galactose-containing 
glycans (25). 
 When the array screening was performed at 
multiple different concentrations, the absolute 
intensity changed but the overall pattern 
remained the same. Analysis of binding across a 
range of concentrations confirmed that for most 
receptors the fluorescence observed was linearly 
related to the input concentrations of zymosan 
(Fig. 4C). This relationship indicates that the 
ligands were below saturating concentrations 
and makes the relative results broadly 
comparable regardless of concentration. 
 
Strain-dependent binding of E. coli to different 
C-type lectins 
 Laboratory strains of E. coli were used to test 
methods for preparing bacterial samples to 
screen against the lectin array. Initially, labeling 
of cells of strain BL21(DE3) by treatment with 
the membrane-permeable derivative of 
fluorescein, carboxyfluorescein diacetate 
succinimidyl ester (CFDA-SE), was investigated 
(26). Compared to direct surface labeling with 
fluorescein isothiocyanate (FITC), this reagent 
primarily reacts with amino groups inside the 
cells, increasing the intensity of labeling and 
also reducing the potential for modification of 
the surface properties of the bacteria. 
 Screening of the lectin array directly with 
live bacteria or following paraformaldehyde 
fixation of the bacteria gave similar results (Fig. 
5A). Compared to zymosan, a more restricted set 
of receptors gave signals for the bacterial 
samples. Many of the membrane receptors and 
serum collectins that bind mannose-containing 
glycans bound well to the bacteria, but there are 
notable exceptions, such as conglutinin, 
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Endo180, dectin-2 and dectin-1, which bound 
well to zymosan but not to the bacteria. 
Generally lower signals were observed for 
galactose-specific receptors, but again there was 
selective binding: to one of the subunits of the 
asialoglycoprotein receptor, to the scavenger 
receptor C-type lectin and to the Kupffer cell 
receptor. 
 Bacteria could also be labeled with 
fluorescent proteins (27). Comparing the results 
for strain BL21(DE3) expressing green 
fluorescent protein (GFP) to the chemically 
labeled cells shows very good concordance of 
results (Fig. 5A). Compared to chemical 
labeling, expressing fluorescent proteins can be 
more species-restricted, since appropriate 
promotors need to be used for expression. 
However, many bacteria expressing fluorescent 
proteins have been developed for use in 
endocytosis assays, for example, and the results 
shown here indicate that such samples can be 
adapted for use in screening the array (27). 
 Lipopolysaccharide (LPS) on the surface of 
the outer membrane of E. coli strain BL21(DE3) 
contains inner and outer core structures, but no 
O-antigen extensions (Fig. 5B) (28). Residues at 
the non-reducing termini of these glycans are 
potential targets for the lectins that were 
observed to bind the bacteria. The presence of 
some terminal galactose residues is consistent 
with the observed binding of galactose-specific 
lectins, and the presence of glucose and GlcNAc 
residues might account for binding of receptors 
that bind mannose-related sugars. However, 
robust binding is observed for ClearColi 
BL21(DE3) cells, a derivative of strain 
BL21(DE3) that has only the lipid A portion of 
LPS (Fig. 5C). The close similarity in the 
binding patterns for BL21(DE3) and ClearColi 
BL21(DE3) cells suggests that there are other 
targets besides those on LPS. 
 A further comparison was made with E. coli 
strain K12, which also lacks an O-antigen and 
has an LPS outer core structure distinct from the 
LPS on BL21(DE3) (29). Compared to strain 
BL21(DE3), broadly similar binding to lectins 
that bind mannose-type sugars was observed, but 
there was little binding to any of the galactose-
specific receptors, even though there is a 
galactose residue in the LPS core glycan (Fig. 
5C). These results are consistent with the 
suggestion that a significant component of the 
binding to several of the receptors is LPS-
independent, probably reflecting the presence of 
additional glycosylated structures on the surface 
of the outer membrane. 
 Two examples of pathogenic E. coli 
serotypes that have been isolated from human 
and cattle were also tested. Strain E2348/69 
(O127:H6), a commonly used prototype entero-
pathogenic strain, showed strong binding to 
almost all of the galactose-specific receptors, 
with the exception of the scavenger receptor 
C-type lectin, which has a narrow specificity 
for galactose in the context of the Lewisx 
trisaccharide (Fig. 6A). The strong binding 
correlates with the presence of galactose in the 
repeat unit of the O127 polysaccharide (Fig. 
6B) (30). The galactose residue present in each 
copy of the backbone repeat would be a target 
for the galactose-binding C-type lectins, since 
it retains free 3- and 4-OH groups. The 
adaptive immune response to most bacteria is 
dominated by the O-antigens, but these results 
suggest that some O-antigens could also be 
targets for receptors of the innate immune 
system.   
 In contrast, enterohemorrhagic E. coli strain 
EDL933 (O157:H7) binds very few receptors on 
the array, although CD23 and LSECtin show 
consistent signals (Fig. 6A). There is no obvious 
target for binding to these receptors in the O-
antigen structure (Fig. 6B) (31). If found at the 
non-reducing termini of the polysaccharides, the 
constituent sugars GalNAc, glucose and fucose 
would be potential targets for receptors. 
However, the absence of binding to most of the 
receptors indicates that there are few such 
terminal sugars exposed on the O157:H7 strain. 
The finding that terminal sugars are not common 
targets in the O157:H7 strain, in comparison to 
the strong binding to the O127:H6 strain to 
multiple receptors, suggests that binding to O-
antigens is likely to be dominated by internal 
sugars that have appropriately exposed OH 
groups. The poor binding of the O157:H7 strain 
to most receptors also demonstrates that 
expression of O-antigens lacking target residues 
provides a way to escape detection by the innate 
immune system. Many common modifications, 
such as methylation and acetylation, block the 3- 
and 4-OH groups and would thus prevent 
binding (32). 
 One possible target for binding across 
multiple bacterial strains is enterobacterial 
common antigen, which can appear in a linear, 
lipid-linked form on the surface of the outer 
membrane (33). Terminal GlcNAc residues in 
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the trisaccharide repeat might be potential 
targets for some of the receptors. The 
observation that the O157:H7 strain does not 
bind to most of the receptors that would be 
expected to interact with GlcNAc suggests that 
this is not a common target, although the extent 
to which the antigen is surface expressed in 
different strains is not fully characterized. 
 
Distinct binding of capsulated and un-
encapsulated Klebsiella pneumoniae 
 Wild type K2:O1 Klebsiella pneumoniae, a 
hyperviscous pathogen for human and cattle, is 
coated with a capsule consisting of a glucose- 
and mannose-containing backbone, with 
glucuronic acid side branches (Fig. 7A) (34). 
Screening against the lectin array revealed 
binding to two receptors, langerin and LSECtin. 
The fact that the capsule is the target for binding 
to these receptors was demonstrated by 
screening a mutant strain that lacks the capsule 
(Fig. 7B). In contrast to the wild type strain, the 
mutant binds to almost all of the galactose-
specific receptors and not to langerin and 
LSECtin. The galactose-dependent binding 
probably reflects exposure of the LPS glycans 
that contain galactopyranose residues. However, 
in this case it would have to be terminal residues 
that bind, because the linkages in the backbone 
would preclude interaction of internal residues 
with any of the receptors (Fig. 7A) (35). 
Comparison of encapsulated and unencapsulated 
strains indicates that the outer polysaccharide 
shields the LPS from receptors and dominates 
the spectrum of interactions with glycan-binding 
receptors. 
 The 1-4 and 1-3 linkages in the backbone of 
the capsular polysaccharide would block binding 
to the 3- and 4-OH groups of these residues, 
making them unavailable to interact with 
langerin and LSECtin (Fig. 7A). However, in the 
absence of binding to any of the other receptors 
that recognize these sugars, it seems unlikely 
that interactions with nonreducing terminal sugar 
residues could account for the observed binding. 
Langerin does bind negatively charged sulfated 
sugar residues (36), but testing of simple 
glucuronic acid methyl glycoside in a solid 
phase binding competition assay showed only 
very weak interaction (data not shown). It 
remains possible that the glucuronic acid forms 
part of a more complex binding epitope. 
 
Receptors that bind Gram-positive 
Staphylococcus aureus 
 Probing of the lectin array with S. aureus, a 
Gram-positive bacterium that has been isolated 
from human and cattle, revealed binding to a 
more limited set of receptors compared to E. coli 
(Fig. 8A). The Wood 46 strain of S. aureus lacks 
protein A and is tarS+/tarM-, leading to 
expression of β- but not α-linked surface 
GlcNAc (37). Similar results were obtained with 
independent preparations of labeled bacteria. 
The main receptor that gives a relatively strong 
signal with S. aureus but not with E. coli is 
CRD2 of Endo180. Although this receptor is 
classified with the mannose-type binding sites, it 
shows a very strong preference for GlcNAc 
compared to other monosaccharides (38). It is 
likely that the binding observed correlates with 
the ability of this CRD to bind to β-linked 
GlcNAc that decorates the wall teichoic (Fig. 
8B) (39). These residues would also be targets 
for binding of other receptors such as DC-SIGN. 
However, it is striking that the mannose receptor 
and langerin show little or no binding in spite of 
their ability to interact with GlcNAc as a 
monosaccharide (40). In contrast, LSECtin, a 
receptor previously associated with binding 
GlcNAcβ1-2Man structures on truncated glycans 
of viruses (41), gives a strong signal. Although 
the LSECtin result would appear to be consistent 
with GlcNAc binding on S. aureus, the primary 
binding residue observed in viral glycans is the 
mannose residue. The array data suggest that 
there are important aspects to the specificity of 
some of the receptors that remain to be 
investigated both to explain why receptors such 
as langerin do not bind GlcNAc in the context of 
the teichoic acid and to identify novel modes of 
ligand binding in other cases such as LSECtin. 
 As with the membrane receptors, there is 
striking specificity in the binding to a subset of 
the collectins: the four serum collectins MBP-A, 
MBP-C, CL-43, and CL-46 give strong signals, 
but conglutinin, another serum protein, does not. 
The binding sites in MBP-A and MBP-C are 
relatively unencumbered, so that they interact 
equally well with mannose and GlcNAc (42). 
However, the monosaccharide-binding 
specificity of both conglutinin and CL-46 is for 
GlcNAc (43). The difference in their interaction 
with S. aureus suggests that, as in the case of the 
mannose receptor and langerin, the specific 
structural context of the GlcNAc linked to 
teichoic acid might limit the interaction with 
 at RO
Y
A
L V
ET CO
LL./LIBRA
RIA
N
 on M
arch 10, 2020
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 7 
 
conglutinin. It is more difficult to explain the 
observed strong interaction with CL-43, which at 
the monosaccharide level binds best to mannose. 
The results suggest that there may be nuances in 
the ligand-binding specificities of the various 
collectins that have not previously been 
recognized, or that other ligands are present on 
the surface of these bacteria. 
 
Receptor for Mycobacterium bovis 
 Mycobacteria have a complex membrane 
structure decorated with novel classes of glycans 
compared to the other bacteria investigated here, 
and there are corresponding differences in the 
ability of different receptors to interact with 
labeled M. bovis (Fig. 9A) (44). Within the 
collectin family, for instance, the strongest 
signals are observed for CL-43 and CL-46, 
which is not observed for any of the other 
bacteria tested. While much of the binding can 
be explained by interaction with mannose caps 
on the lipoarabinomannans of the outer 
membrane, the results suggest that the collectins 
may be particularly suited to binding these α1-2 
linked mannose structures (Fig. 9B). In a similar 
way, there is some binding to dectin-2, for which 
Manα1-2Man is a preferred ligand (45,46). 
Dectin-2 binds to zymosan, which contains such 
structures, but not to the other bacteria tested on 
the array. Most of the other receptors for 
mannose-type ligands also bind the 
mycobacteria, including DC-SIGN and the 
mannose receptor, which have been suggested to 
be the major routes for entry into cells (47). 
However, a unique feature of mycobacteria 
binding to the array is that there is some 
interaction with mincle, a receptor that does not 
bind to the Gram-negative bacteria. Although it 
is likely that the mannose-binding receptors 
mediate entry into cells, mincle binding to 
trehalose dimycolate in the bacterial outer 
membrane is an important signaling mechanism 
in macrophages (48) and the observation that 
binding is sufficient to tether the mycobacteria to 
the immobilized receptor confirms that this 
ligand is accessible on the surface of the intact. 
 
Discussion 
 The design of the lectin array described here 
includes a number of important technical 
features associated with the use of biotin tags for 
immobilization. A key point is the use of simple 
bacterial expression systems that are easy to 
generate and give high yields. Biotin tagging 
takes place co-translationally in the expression 
system. The activity of the proteins is confirmed 
by affinity chromatography on sugar ligands. 
Using lectins with confirmed activity gives 
confidence in negative as well as positive 
results. The streptavidin layer creates a soft 
protein surface. Because the tag is on the 
opposite side of the protein from the sugar-
binding site, it does not interfere with binding 
and orientation of the binding sites away from 
the layer is assured. Including additional 
domains beyond the CRD, particularly coiled-
coil neck domains, allows formation of 
oligomers in which the CRDs are held in the 
native orientation. The biotin tagged proteins can 
also be used in follow-up experiments, such as 
using fluorescently labeled streptavidin to create 
probes for investigating the nature of ligands in 
microbes that are found to bind to specific 
receptors. 
 An advantage of the lectin array is the ability 
to provide an unbiased search for receptors that 
bind to a particular micro-organism, independent 
of any knowledge of what sugar structures are 
present on the microbe. This feature allows 
screening with organisms that have not been 
subjected to extensive glycomic analysis, but it 
also has the potential to reveal unrecognized 
types of glycosylation even in relatively well 
characterized microbes. Use of minimally 
modified micro-organisms to screen the array 
demonstrates accessibility of glycan ligands in 
the context of intact micro-organisms. A further 
advantage of the array approach is the ability to 
compare binding of a bacterium or other micro-
organism to multiple potential receptors in one 
assay. The use of a species-specific array also 
makes it possible to perform cross-species 
studies to identify differences in binding of 
microbes between different host species. Such 
results can potentially lead to discovery and 
understanding of zoonosis. Given that many C-
type lectins are expressed on cells that sample 
mucosal surfaces, this knowledge can be used to 
identify new intervention strategies to reduce 
pathogen pressure on surfaces, to prevent entry 
of pathogens, or for the development of 
carbohydrate-based vaccines. 
 Interesting outcomes from these initial 
applications of the array, summarized in the 
heatmap in Fig. 10, include unexpected aspects 
of microbial glycosylation and insights into 
novel binding properties of some of the 
receptors. The binding of laboratory strains of E. 
coli to multiple receptors, apparently 
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independent of the presence of even core sugars 
of LPS, indicates that there are additional types 
of glycosylation exposed on these cells. Potential 
targets include novel types of protein-linked 
glycosylation (49). The O-antigens found on the 
LPS of pathogenic strains of E. coli are strain-
specific, so they can bind to different receptors 
depending on the sugar composition of a given 
strain. These structures dominate the antibody 
response to different strains, but the results with 
the array highlight the fact that different O-
antigens will also lead to different interactions 
with the innate immune system. In principle, 
innate immune recognition of common 
structures allows immediate response to whole 
classes of bacteria in a strain-independent 
manner. However, comparing the results for 
laboratory strains in Fig. 5 with the pathogenic 
strains in Fig. 6 reveals very different patterns of 
interactions. Common structures on the surface 
of laboratory strains, which lack O-antigens, 
interact with a range of receptors, but these 
interactions are dwarfed by the dominant strain-
specific interactions when O-antigens are 
present. 
 Contrasting the interactions of different 
naturally occurring strains of bacteria with 
lectins on the array provides insights into the 
molecular nature of potential ligands, such as the 
O-antigens. The analysis of Klebsiella mutants 
demonstrates the power of combining the array 
with bacterial mutants as an additional way to 
define potential ligands. In this instance, it was 
possible to distinguish interactions with the 
capsule and LPS. In other cases, the biotin-
tagged CRDs can be used as probes to identify 
target molecules, for example by using 
streptavidin complexes to probe blots of 
glycoproteins and glycolipids extracted from the 
bacteria. 
 The results with the array also reveal novel 
aspects of receptor specificity, negative as well 
as positive. For example, there are striking 
differences in the interactions of DC-SIGN on 
the one hand and the mannose receptor and 
langerin on the other, even though these 
receptors bind a similar spectrum of 
monosaccharides. The specific S. aureus strain 
used in the present study shows particularly 
strong preferential binding to DC-SIGN, but M. 
bovis also gives a stronger signal with DC-
SIGN. Although all of these receptors can bind 
to the putative GlcNAc target on S. aureus and 
to terminal Manα1-2Man structures that appear 
in the caps of mycobacterial lipo-
arabinomannans, the context in which these 
binding epitopes are presented seems to 
differentially affect their interactions with 
receptors. 
 Several of the receptors on the array show 
interactions that would not have been expected 
based on what is known about their interactions 
with defined glycan ligands. For example, on 
mammalian glycan arrays the scavenger receptor 
C-type lectin binds very selectively to Lewisx-
containing oligosaccharides (50), but it also 
seems to interact with the exposed, galactose-
containing LPS of the Klebsiella capsule mutant. 
Langerin and LSECtin bind especially well to 
sugars present in the capsule of Klebsiella, even 
though the capsule structure does not contain 
any obvious targets based on what is known 
about the specificities of these two receptors. On 
glycan arrays, LSECtin binds to 
oligosaccharides containing the disaccharide 
GlcNAcβ1-2Man (41), but this narrow 
specificity does not explain its interactions with 
enterohemorrhagic E. coli, Klebsiella and S. 
aureus. These results suggests that further 
screening with a broader range of potential 
oligosaccharide ligands will reveal novel types 
of ligands. 
 The array also highlights differences in the 
ways that the serum collectins interact with 
micro-organisms. The serum mannose-binding 
proteins and the ruminant-specific proteins CL-
43 and CL-46 all interact with mycobacteria, 
although the additional ruminant-specific 
collectin, conglutinin, does not. The proliferation 
of collectins in cows might be related to the 
evolutionary history of infection with 
mycobacteria. The collectins also interact 
particularly well with Gram-positive S. aureus, 
but poorly with the Gram-negative strains tested. 
This selectivity correlates with the fact that 
infections associated with deficiency of human 
mannose-binding proteins are often caused by 
Gram-positive species (51). These results 
suggest that innate immune responses have 
evolved to target specific classes of potential 
pathogens, an idea that is also supported by the 
observations that both dectin-1 and dectin-2 
appear to interact selectively with fungi rather 
than bacterial targets. The ability to compare 
wild type and naturally occurring mutant forms 
of receptors such as dectin-1 on the array also 
provides a way of investigating how 
polymorphisms that affect the sequences of 
receptors may change the way that they interact 
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with pathogens. In some cases, such changes 
may explain disease phenotypes (20). 
 Future developments of the lectin array can 
include addition of other classes of glycan-
binding proteins to the array. Other lectin groups 
in which multiple members have potential roles 
in recognition of micro-organism include the 
siglecs and the galectins. The availability of 
bacteria expression systems for the sugar-
binding domains of these proteins will facilitate 
addition of biotin tags using the approach 
described here for co-expression with biotin 
ligase (52,53). However, in cases where the use 
of mammalian expression systems is preferable, 
it is also possible to attach the biotin to the 
appended target sequence after isolation of the 
protein. Such an approach has been employed 
for the multidomain extracellular portion of the 
mannose receptor, which has been expressed in 
secreted form in Chinese hamster ovary cells, 
purified by affinity chromatography and treated 
with biotin ligase before immobilization (data 
not shown). The approach demonstrated here for 
the cow lectins can also be readily duplicated for 
receptors from other organisms, including 
humans and mice. In addition, further categories 
of micro-organisms, including viruses and fungi, 
can be screened against the array. 
 
Experimental Procedures 
Database screening 
 Genes encoding proteins that contain 
potential CRDs were identified by screening the 
National Center for Biotechnology Information 
gene database using Bos taurus and CLECT as 
keywords. The DNA sequence of the region 
encoding a potential CRD was extracted from 
each file in reference assembly version ARS-
UCD1.2. All of the sequences containing amino 
acid residues at appropriate positions to form the 
conserved Ca2+-binding site were identified 
based on the database annotation and 
comparison with the human and mouse 
sequences. CRDs selected for inclusion on the 
initial array were subjected to cluster analysis 
with Clustal W and the results were used to 
generate a cladogram using Dendroscope 3 
(54,55). The aligned sequences (Figure S1), 
along with previous instances in which human 
orthologs have been expressed, were used to 
define regions of each protein to be expressed. 
 
Expression systems 
 Fragments for making expression vectors 
were generated by PCR amplification using 
primers that encode the biotin tag at the 3' or 5' 
end and restriction sites to allow movement into 
the expression vector. cDNAs were amplified 
using Advantage2 polymerase (Takara) (Fig. S2-
S28). cDNA libraries prepared from various 
tissues as indicated in Table 1 were obtained 
from Zyagen through AMSBio. Amplified 
fragments were cloned into vector pCRIITopo 
(Life Technologies) and the sequences were 
confirmed. For Endo180, a synthetic version of 
CRD 2 predicted from the gene sequence was 
synthesized by GeneArt (Fig. S19). Restriction 
fragments were transferred to the pT5T 
expression vector (56). 
 Biotin-tagged CRDs were expressed from the 
T7 promotor in plasmid pT5T in E. coli strain 
BL21(DE3) which also carried plasmid pBirA, 
which encodes biotin ligase (21). Bacteria were 
grown with shaking in Luria-Bertani medium 
containing 50 µg/ml ampicillin and 25 µg/ml 
chloramphenicol at 37 °C. Isopropyl-β-D-
thiogalactoside was added to a concentration of 
100 mg/L when the A550 reached 0.7, followed 
by a further 150 min incubation. Bacteria were 
harvested by centrifuging at 4000 ×g for 15 min 
at 4 °C, washed with 10 mM Tris–HCl, pH 7.8 
and pelleted at 10,000 ×g for 10 min at 4 °C. 
 Cell pellets from 6 liters of culture in 200 ml 
of 10 mM Tris-Cl, pH 7.8 were sonicated four 
times for 1 min at full power using a Branson 
250 sonicator. Inclusion bodies recovered by 
centrifugation for 15 min at 10,000 xg in a 
Beckman JA-14 rotor were dissolved by 
homogenization in 100 ml of 6 M guanidine-
HCl, 100 mM Tris-Cl, pH 7.0. 2-
Mercaptoethanol was added to a final 
concentration of 0.01% and the mixture was 
incubated for 30 min at 4 °C and centrifuged for 
30 min at 40,000 xg in a Beckman 70.1Ti rotor. 
 Proteins were renatured by one of three 
different protocols, as indicated in Table 1. In 
the direct dialysis protocol, the guanidine 
solution was dialyzed against three changes of 2 
liters of renaturation buffer (0.5 M NaCl, 25 mM 
Tris-Cl, pH 7.8, 25 mM CaCl2). For renaturation 
with Triton detergent, 10 ml of 10% Triton X100 
was added to the guanidine solution before 
dialysis. In the dilution protocol, the guanidine 
solution was dripped into 400 ml of renaturation 
buffer before dialysis against three changes of 4 
liters of renaturation buffer. For proteins that 
bound weakly to the affinity columns, material 
renatured by the direct protocol was further 
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dialyzed against three changes of water, 
lyophilized, and resuspended in a 10-fold 
reduced volume of loading buffer, consisting of 
0.5 M NaCl, 25 mM Tris-Cl, pH 7.8, 25 mM 
CaCl2 for SP-A and a 20-fold reduced volume of 
loading buffer, consisting of 0.15 M NaCl, 25 
mM Tris-Cl, pH 7.8, 25 mM CaCl2 for LSECtin, 
before affinity chromatography.   
 In most cases, the final dialyzed samples 
were centrifuged for 30 min at 20,000 xg in a 
Thermo Scientific F21S-8x50g rotor or 
Beckman JA-14 rotor and applied to 10-ml 
affinity columns made with appropriate 
immobilized sugar ligands (57). Columns were 
washed with 10 ml of 150 mM NaCl, 25 mM 
Tris-Cl, pH 7.8, 25 mM CaCl2 and eluted with 
fifteen 1-ml aliquots of 150 mM NaCl, 25 mM 
Tris-Cl, pH 7.8, 2.5 mM EDTA. Fractions were 
examined on SDS-polyacrylamide gels 
containing 17.5% polyacrylamide. The SP-A 
protein eluted early, during the wash, so 
fractions were collected earlier. Wash fractions 
containing SP-A protein were pooled, dialysed 
against water, lyophilised, resuspended in 1 ml 
of loading buffer containing 0.15 M NaCl, and 
repurified over the 10-ml mannose column. 
 In two instances, dectin-1 and the collectin 
ColL1, the CRDs could not be purified by 
affinity chromatography. Following renaturation 
by the Triton and lyophilized protocols 
respectively, these proteins were dialyzed 
against or resuspended in 50 mM Tris-Cl, pH 
7.8, and loaded onto a 1-ml MonoQ ion 
exchange column, which was eluted with a 
gradient from 0 to 0.5 M NaCl containing 50 
mM Tris-Cl, pH 7.8. Fractions containing the 
renatured CRDs, identified by SDS-
polyacrylamide gel electrophoresis, were pooled, 
dialyzed against water and lyophilized. ColL1 
and CRDs 4+5 of the mannose receptor were 
further purified by gel filtration chromatography 
on a 1 x 30 cm Superdex S75 column eluted 
with 100 mM NaCl, 10 mM Tris-Cl, pH 7.8, 2.5 
mM EDTA and the purified protein was again 
detected by SDS-polyacrylamide gel 
electrophoresis. 
 
Labeled micro-organisms 
 Bacterial strains used are summarized in 
Table S1. Fluorescein-labeled preparations of 
zymosan from S. cerevisiae, E. coli K12, and the 
Wood 46 strain of S. aureus were obtained from 
Molecular Probes (Thermo Scientific). Heat-
killed S. aureus Wood 46 cells from Invivogen 
suspended in 1 ml of 0.1 M sodium carbonate, 
pH 9.0, were treated with 100 µl of 1 mg/ml 
FITC in dimethylsulfoxide. For labeling with 
CFDA-SE, bacteria were washed and suspended 
in phosphate-buffered saline. An aliquot (1 ml) 
was treated with 2 µl of 50 mM CFDA-SE in 
dimethylsulfoxide. After reaction for 6-18 h with 
gentle mixing at room temperature, cells were 
again washed twice with phosphate-buffered 
saline, treated for two hours with 5% 
paraformaldehyde at room temperature, and 
finally washed three times with Tris-buffered 
saline. 
 A plasmid containing a cDNA for enhanced 
GFP in vector pET28a, a kind gift of Neil 
Fairweather, was transformed into E. coli strains 
BL21(DE3) and into competent ClearColi 
BL21(DE3) cells obtained from Lucigen. Other 
E. coli and K. pneumoniae strains were 
transformed with plasmids expressing GFP from 
pACYC184 (enteropathogenic E. coli) or pUltra-
GFP/Gn (all other strains) (58,59). Cells were 
grown to stationary phase, washed in phosphate-
buffered saline, fixed for 30 min in 5% 
paraformaldehyde in phosphate-buffered saline, 
and washed with Tris-buffered saline. 
 M. bovis strain bacillus Calmette-Guerin 
Pasteur ΔpanCD expressing yellow fluorescent 
protein from promotor Psmyc  contained vector 
pCB22-Turbo635-ASV-YFP. This plasmid was 
created by cloning the region encoding the 
Turbo635-ASV/msfYFP operon from plasmid 
pCharge-ASV-YFP into the multiple cloning site 
of shuttle vector pCB22, which contains both an 
E. coli and a mycobacterial origin of replication, 
with a hygromycin-resistance cassette and a 
panCD operon driven by the constitutive 
BCG_3667c promoter, followed by the multiple-
cloning site (60). Mycobacteria were grown at 
37 °C in Middlebrook 7H9 broth (BD 
Diagnostics) supplemented with 0.05% Tween-
80 (Sigma), 0.2% glycerol (Sigma) and 10% 
oleic acid- albumin-dextrose-catalase (BD 
Diagnostics). To obtain fluorescence levels 
above the background threshold, the fluorescent 
mycobacteria were additionally labelled with 
CFDA-SE. Log-phase cultures were washed 
twice and suspended in 1 ml of phosphate-
buffered saline + 0.05% Tween-80 at a 
concentration of 7.0 x 108 cells/ml.  Bacteria 
were treated with 2 µl of 50 mM CFDA-SE, 
incubated with gentle shaking for 18 h at 370C, 
washed with Tris-buffered saline, fixed with 5% 
formaldehyde for 2 h at room temperature and 
further washed with Tris-buffered saline.  
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 Bacteria were quantified by counting of 
suitable dilutions in a Helber counting chamber 
and total fluorescence of the samples was 
determined for an aliquot of cells diluted in PBS 
and applied to a 96-well plate. 
 
Array screening 
 All procedures were conducted in binding 
buffer containing 0.15 M NaCl, 25 mM Tris-Cl, 
pH 7.8, 2.5 mM CaCl2. Biotinylated receptor 
fragments were dissolved in binding buffer 
containing 0.1% bovine serum albumin. 
Streptavidin-coated wells from Pierce (Thermo 
Scientific) were incubated overnight at 4 °C with 
100 µl aliquots of these coating stocks and the 
wells were washed three times with binding 
buffer. Labeled micro-organisms suspended in 
binding buffer containing 0.1% bovine serum 
albumin were added to duplicate wells in 100 µl 
aliquots. After incubation for 3 h at 4 °C, wells 
were washed 3 times with binding buffer and 
scanned directly on a Victor3 multiwell plate 
reader (PerkinElmer). 
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Figure legends 
 
Figure 1. Cow C-type CRDs. Dendrogram shows a comparison of the CRD sequences for the CRDs 
from cow C-type lectins included in the lectin array. The aligned sequences are shown in Figure S1. 
The lectin groups correspond to the human classification www.imperial.ac.uk/research/animallectins 
(1). Only a single form of DC-SIGN (green) is found in cows, rather than the multiple related genes in 
humans and mice. Several collectins are ruminant-specific (red). 
 
Figure 2. Lectin organization and immobilization strategy. A, domain organization of membrane-
bound receptors containing C-type CRDs. Many of the receptors are type 2 transmembrane proteins 
which often assemble into oligomers (left). The mannose receptor and Endo180 contain multiple C-
type lectin-like domains, only some of which are involved in binding sugars (middle). Other receptors 
interact with other types of polypeptides, such as the FcRγ subunit (right). B, arrangement of domains 
in collectins. C, C-type CRD from dectin-2 illustrating the location of the N- and C-termini opposite 
to the ligand-binding site. Prepared from Protein Data Bank file 5VYB using PyMol. D, arrangement 
of lectin fragments on streptavidin-coated wells. In addition to the fragments employed in the initial 
test array described here, the extracellular portion of the mannose receptor expressed with a C-
terminal biotinylation sequence and treated with biotin ligase in vitro is also depicted. E, sequence of 
biotinylation tag showing site of attachment of biotin to a lysine side chain. 
 
Figure 3. Demonstration of saturation of streptavidin-coated wells with biotin-tagged receptors. 
Examples of screening with zymosan at of 5 x 106 particles/ml for three receptors are shown. 
 
Figure 4. Validation of lectin array using yeast zymosan. A, structures of polysaccharides in 
zymosan. B, screening of lectin array with FITC-labeled zymosan extract from S. cerevisiae. Labeled 
zymosan at a concentration of 5 x 106 particles/ml was used in the screening. The results are plotted 
relative to the maximal value of 215,000 fluorescence units for binding to dectin-1. In this and 
subsequent figures, error bars represent standard deviations for duplicate samples. C, binding as a 
function of zymosan concentration. Zymosan was screened against a receptor panel at three different 
concentrations. 
 
Figure 5. Testing of lectin array with laboratory E. coli strains. A, comparison of different 
methods for preparing bacterial strain BL21(DE3) prior to screening of array. Cells expressing GFP 
and fixed with paraformaldehyde were screened at 1 x 108 cells/ml and cells labeled with CFDA-SE 
followed by paraformaldehyde fixation or used directly were screened at 3 x 108 cells/ml. For 
comparison, results for all three samples were normalized to the SP-D result, which was the highest 
value for both of the CFDA-SE samples. The values were 40,400, 16,400, and 39,000, fluorescence 
units respectively. B, summary of structures of LPS from three laboratory strains of E. coli. C. binding 
of different strains of E. coli to the lectin array. Strain K12 cells were labeled with FITC (1.5 x 107 
cells/ml) and BL21(DE3) (5 x 107 cells/ml) and the ClearColi derivative of BL21(DE3) (3 x 108 
cells/ml) were expressing GFP. All results were normalized to the signals for CD23, which was the 
strongest signal for K12 and BL21(DE3). The signals were 56,000, 49,700, and 46,200 fluorescence 
units for K12, BL21(DE3) and BL21(DE3) ClearColi, respectively. 
 
Figure 6. Comparison of enteropathogenic and enterohemorrhagic E. coli strains binding to the 
lectin array. A, bacteria expressing GFP were grown to stationary phase and fixed with 
paraformaldehyde. Enteropathogenic E. coli strain E2348/69 (O127:H6) was screened at 7 x 108 
cells/ml and enterohemorrhagic E. coli strain EDL933 (O157:H7) was screened at 5 x 108 cells/ml. 
Results were normalized to the values for ASGPR1 (41,400 fluorescence units) and LSECtin (51,800 
fluorescence units), respectively. B, structures of two repeat units from the O127 and O157 outer 
polysaccharides of LPS are shown. Purple shading is used to highlight galactose residues that have 
free 3- and 4-OH groups in the O127 polysaccharide and would be potential targets for galactose-
binding C-type CRDs. 
 
 at RO
Y
A
L V
ET CO
LL./LIBRA
RIA
N
 on M
arch 10, 2020
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
 16 
 
Figure 7. Effect of capsule on interaction of K. pneumoniae with lectins on the array. A, summary 
of structures of the K2 capsule and the O1 outer polysaccharide structure of K. pneumoniae. B, lectin 
array was screened with two stains of K. pneumoniae with the K2:O1 serotype, strains 43816 and 
B5055, as well a mutant derived from the B5055 strain in which the wzb/c gene is inactivated to 
prevent capsule formation. Cells expressing GFP were grown to stationary phase and screened against 
the array at concentrations of 9 x 108, 4 x 108, and 7 x 108 cells/ml, respectively. Results were 
normalized to the signals for LSECtin for the wild type strains (155,000 and 37,300 fluorescence 
units) and ASGPR1 for the mutant strain (796,000 fluorescence units). 
 
Figure 8. S. aureus binding to lectin array. A, heat-killed cells of the Wood 46 strain of S. aureus 
labeled with FITC were used to screen the array at a concentration of 1.25 x 108 cells/ml. Results were 
normalized to the signal of 109,000 fluorescence units, which was obtained for LSECtin. B, schematic 
diagram of wall teichoic acid from S. aureus, showing relative location of α- and β-linked GlcNAc 
residues. Only β-linked residues are present in this strain. 
 
Figure 9. M. bovis binding to lectin array. A, M. bovis bacillus Calmette-Guerin expressing yellow 
fluorescent protein growing in log phase were further labeled with CFDA-SE, fixed with 
paraformaldehyde and used to screen the lectin array at a concentration of 4 x 108 cells/ml. Results 
were normalized to the value for binding to CL-43, which was 30,000 fluorescence units. B, structure 
of mannose caps on lipo-arabinomannan in the outer membrane of M. bovis. 
 
Figure 10. Comparative heatmap for zymosan and bacteria binding to lectin array. Binding of 
laboratory and pathogenic strains of E. coli, as well as K. pneumoniae, M. bovis and S. aureus are 
compared to zymosan results using a heatmap. Results for each organism are normalized to the 
maximum value for that organism as indicated in legends to Figs 4-9. 
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Table 1. Biotin-tagged C-type lectins displayed on lectin array. 
cDNA libraries used for PCR amplification, methods for protein renaturation, and resins used for 
purification are indicated for each protein. 
 
Abbreviation Protein Gene Library Renaturation Resin 
   
MBP-A Mannose-binding protein A MBL1 Liver Direct Mannose 
MBP-C Mannose-binding protein C MBL2 Liver Direct Mannose 
CL-43 Collectin 43 CL43 Liver Direct Mannose 
SP-D Surfactant protein D SFTPD Lung Direct Maltose 
CL-46 Collectin 46 CL46 Liver Direct GlcNAc 
Conglutinin Conglutinin CGN1 Liver Direct GlcNAc 
ColK1 Collectin K1 COLEC11 Liver Direct Mannose 
SP-A Surfactant protein A SFTPA Lung Lyophilized Mannose 
ColL1 Collectin L1 COLEC12 Liver Lyophilized MonoQ 
MMR CRD 4 Mannose receptor CRD 4 MRC1 Liver Direct Mannose 
MMR CRD 4+5 Mannose receptor CRD 4+5 MRC1 Liver Dilution Mannose 
Langerin Langerin CD207 Lung Direct Mannose 
DC-SIGN DC-SIGN CD209 Spleen Direct Mannose 
Prolectin Prolectin CLEC17A Spleen Direct Mannose 
CD23 CD23 FCER2 Spleen Direct Mannose 
LSECtin LSECtin CLEC4G Liver Lyophilized Mannose 
Endo180 CRD 2 Endo180 MRC2 - Direct GlcNAc 
Mincle Mincle CLEC4E Liver Direct Trehalose 
Dectin-2 Dectin-2 CELC6A Lung Triton Mannose 
Dectin-1 ECD wt Dectin-1 wild type CLEC7A Lung Triton MonoQ 
Dectin-1 ECD mut Dectin-1 mutant CLEC7A Lung Triton MonoQ 
ASGPR1 Asialoglycoprotein receptor 1 ASGR1 Liver Direct Galactose 
ASGPR2 Asialoglycoprotein receptor 2 ASGR2 Liver Direct Galactose 
MGL Macrophage galactose receptor CLEC10A Lung Dilution Galactose 
SRCL Scavenger receptor C-type lectin COLEC12 Lung Direct Galactose 
KCR CRD Kupffer cell receptor CLEC4F Liver Dilution Galactose 
KCR ECD Kupffer cell receptor trimer CLEC4F Liver Dilution Galactose 
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